www.fdanews.com/articles/61664-glaxosmithkline-settles-inflation-claim
GLAXOSMITHKLINE SETTLES INFLATION CLAIM
August 11, 2006
GlaxoSmithKline Inc. has agreed to pay more than $41 million in restitution to end claims by more than 40 states that it inflated the prices of drugs used by cancer patients and others.
Business Week